3 studies found for:    weill | Open Studies | "Burkitt Lymphoma"
Show Display Options
Rank Status Study
1 Recruiting MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
Conditions: Diffuse Large B-Cell Lymphoma;   Transformed Follicular Lymphoma;   Mantle Cell Lymphoma;   Burkitt's Lymphoma
Intervention: Drug: Alisertib (MLN8237) + Rituximab + Vincristine
2 Unknown  Monoclonal Antibody hA20 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Biological: veltuzumab
3 Recruiting Autologous Transplant in HIV Patients (BMT CTN 0803)
Conditions: Lymphoma;   HIV
Intervention: Procedure: Autologous transplant

Indicates status has not been verified in more than two years